Paul A Mahon United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Paul A Mahon is EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 36,710 shares of UTHR, which is worth approximately $13.6 Million. The most recent transaction as insider was on Jul 21, 2022, when has been sold 6,000 shares (Common Stock) at a price of $111.0 per share, resulting in proceeds of $666,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.7K
0% 3M change
0.3% 12M change
Total Value Held $13.6 Million

PAUL A MAHON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 21 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,397 Common Stock
Jul 07 2022
SELL
Open market or private sale
$1,453,260 $242.21 p/Share
6,000 Reduced 14.15%
36,397 Common Stock
Jul 07 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,397 Common Stock
Jun 16 2022
SELL
Open market or private sale
$1,294,860 $215.81 p/Share
6,000 Reduced 14.15%
36,397 Common Stock
Jun 16 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,397 Common Stock
Jun 02 2022
SELL
Open market or private sale
$1,351,740 $225.29 p/Share
6,000 Reduced 14.15%
36,397 Common Stock
Jun 02 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,397 Common Stock
May 19 2022
SELL
Open market or private sale
$1,104,720 $184.12 p/Share
6,000 Reduced 14.15%
36,397 Common Stock
May 19 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,397 Common Stock
May 05 2022
SELL
Open market or private sale
$1,146,600 $191.1 p/Share
6,000 Reduced 14.15%
36,397 Common Stock
May 05 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,397 Common Stock
Apr 21 2022
SELL
Open market or private sale
$1,131,240 $188.54 p/Share
6,000 Reduced 14.15%
36,397 Common Stock
Apr 21 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.37%
42,487 Common Stock
Apr 07 2022
SELL
Open market or private sale
$1,114,440 $185.74 p/Share
6,000 Reduced 14.12%
36,487 Common Stock
Apr 07 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.37%
42,487 Common Stock
Mar 17 2022
SELL
Open market or private sale
$1,096,080 $182.68 p/Share
6,000 Reduced 14.12%
36,487 Common Stock
Mar 17 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.37%
42,487 Common Stock
Mar 03 2022
SELL
Open market or private sale
$1,046,340 $174.39 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Mar 03 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Feb 17 2022
SELL
Open market or private sale
$1,214,880 $202.48 p/Share
6,000 Reduced 16.5%
30,369 Common Stock
Feb 17 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 14.16%
36,369 Common Stock
Feb 03 2022
SELL
Open market or private sale
$1,200,180 $200.03 p/Share
6,000 Reduced 16.5%
30,369 Common Stock
Feb 03 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 14.16%
36,369 Common Stock
Jan 20 2022
SELL
Open market or private sale
$1,234,260 $205.71 p/Share
6,000 Reduced 16.5%
30,369 Common Stock
Jan 20 2022
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 14.16%
36,369 Common Stock
PAM

Paul A Mahon

EVP & GENERAL COUNSEL
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR